AVANIR Pharmaceuticals
(NASDAQ:AVNR)|
0.28 0.00 (0.00%) Dec 02 - Close |
|
|
|
After-Hours 0.37 +0.09 (32.14%) Tue, 2 Dec 2008 7:40 PM
- Compare AVNR with:
- View: Line | Candlestick
Company Profile
AVANIR Pharmaceuticals
101 Enterprise
Aliso Viejo, CA 92656
United States - Map
Phone: (949) 389-6700
Fax: (310) 691-7150
Website: www.avanir.com
State of incorporation: California
CEO: Keith A. Katkin
Employees: 25
Sector: Healthcare
Industry Group: Drugs
Industry: Drug Manufacturers - Other
Devlop & market novel therqpeutic products
A pharmaceutical company focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases.
Recent news for AVNR
-
AVANIR to Present at the Piper Jaffray 20th Annual Health Care Conference
Business Wire - Nov 25 at 8:30 ET
-
EDGAR Online - Nov 12 at 6:17 ET
-
AVANIR To Present at the Rodman & Renshaw 10th Annual Healthcare Conference
Business Wire - Nov 04 at 8:00 ET
-
AVANIR to Present at the BIOCOM Investor Conference
Business Wire - Oct 21 at 3:30 ET
-
AVANIR Presents Data at American Neurological Association Annual Meeting
Business Wire - Sep 23 at 3:00 ET
-
AVANIR Pharmaceuticals Wall Street Analyst Forum Presentation Transcript
Seeking Alpha - Sep 10 at 2:43 ET
-
AVANIR to Present at The Wall Street Analyst Forum Conference
Business Wire - Sep 03 at 7:30 ET
-
EDGAR Online - Aug 18 at 4:04 ET
-
AVANIR PHARMACEUTICALS Financials
EDGAR Online Financials - Aug 15 at 8:04 ET
-
AVANIR PHARMACEUTICALS Files SEC form 10-Q, Quarterly Report
EDGAR Online - Aug 08 at 2:15 ET